ClinicalTrials.Veeva

Menu

Obesity Effect on Stroke and Cardiovascular Events (OSR)

E

Ege University

Status

Completed

Conditions

Stroke, Acute

Treatments

Diagnostic Test: Obesity assessment

Study type

Observational

Funder types

Other

Identifiers

NCT04062643
2010/101

Details and patient eligibility

About

The relation between obesity and stroke recurrence is still under debate. In this study it has been sought whether baseline obesity is associated with recurrent stroke and major cardiovascular events in a long-time period.

Full description

Five-years follow-up data of Ege Stroke Registry for stroke recurrence and cardiovascular events regarding to obesity were analyzed. Data include age, gender, stroke severity, neuroimaging studies, cardiovascular risk factors. Within the inclusion period, all of the included patients were followed until censoring (10th of December 2011) or readmission because of recurrent stroke, cardiovascular event or death, whichever came first. The Kaplan-Meier method was used for survival analysis. Cox proportional hazard model was applied to identify predictors of recurrent vascular events.

Enrollment

9,285 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All consecutive stroke patients.

Exclusion criteria

  • Incomplete baseline information, other factors making them unsuitable for follow-up,undetermined stroke, subarachnoid hemorrhage.

Trial design

9,285 participants in 2 patient groups

Patients with obesity
Description:
Obesity in those with BMI ≥30 kg/m2
Treatment:
Diagnostic Test: Obesity assessment
Patients without obesity
Description:
Normal weight was considered in the patients with BMI \<30 kg/m2
Treatment:
Diagnostic Test: Obesity assessment

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems